These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6748212)

  • 1. The FDA does not approve uses of drugs.
    Archer JD
    JAMA; 1984 Aug 24-31; 252(8):1054-5. PubMed ID: 6748212
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA extra-label restriction on drugs.
    Varney JE
    J Am Vet Med Assoc; 1983 Dec; 183(12):1372, 1374-5. PubMed ID: 6654717
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA--its role in testing.
    Minno AM
    Pa Med; 1971 Sep; 74(9):57-8. PubMed ID: 5095768
    [No Abstract]   [Full Text] [Related]  

  • 4. Are drugs approved by the FDA safe and risk free?
    Natl Med Leg J; 1991; 2(1):8. PubMed ID: 2018814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approvals: '92 in review.
    Rodman MJ
    RN; 1993 Mar; 56(3):50-4, 56-7. PubMed ID: 8451592
    [No Abstract]   [Full Text] [Related]  

  • 6. New FDA approvals: how to use them, when to suggest them.
    Rodman MJ
    RN; 1992 Mar; 55(3):58-65. PubMed ID: 1546269
    [No Abstract]   [Full Text] [Related]  

  • 7. Should it be easier or harder to use unapproved drugs and devices?
    Flannery EJ
    Hastings Cent Rep; 1986 Feb; 16(1):17-23. PubMed ID: 3514546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA: clinically meaningful data.
    Freund J; Preston LW
    Science; 1971 Jan; 171(3969):334-5. PubMed ID: 4923357
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug efficacy study: FDA yields on fixed combinations.
    Bazell RJ
    Science; 1971 Jun; 172(3987):1013-5. PubMed ID: 4929913
    [No Abstract]   [Full Text] [Related]  

  • 10. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 11. ASHP statement on the use of medications for unlabeled uses.
    Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846
    [No Abstract]   [Full Text] [Related]  

  • 12. Science, drugs, and the Food and Drug Administration.
    De Haen P
    N Y State J Med; 1971 Jul; 71(13):1644-50. PubMed ID: 5284708
    [No Abstract]   [Full Text] [Related]  

  • 13. White paper on the therapeutic equivalence of chemically equivalent drugs.
    Castle WB; Astwood EB; Finland M; Keefer CS
    JAMA; 1969 May; 208(7):1171-2. PubMed ID: 5818716
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring safe and effective medications for children.
    Budetti PP
    JAMA; 2003 Aug; 290(7):950-1. PubMed ID: 12928474
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of investigational drugs--JCAHO.
    Hoffmann RP
    Hosp Pharm; 1988 Oct; 23(10):905, 908-9. PubMed ID: 10290112
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA as an information source for family physicians.
    Rheinstein PH
    Am Fam Physician; 1991 Sep; 44(3):1037-41. PubMed ID: 1877417
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating drugs after their approval for clinical use.
    Ray WA; Griffin MR; Avorn J
    N Engl J Med; 1993 Dec; 329(27):2029-32. PubMed ID: 8018139
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA and drug uses: reprise.
    Nightingale SL
    JAMA; 1985 Feb; 253(5):632. PubMed ID: 3968793
    [No Abstract]   [Full Text] [Related]  

  • 20. Open letter to the FDA: new drug trials must be relevant.
    Vincenti F; Klintmalm G; Halloran PF
    Am J Transplant; 2008 Apr; 8(4):733-4. PubMed ID: 18324977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.